Lexicon Pharmaceuticals Inc
F:LX31
Lexicon Pharmaceuticals Inc
F:LX31
Price:
2.894
EUR
-2.69%
Market Closed
Market Cap:
€418.1m
Wall Street
Price Targets
LX31 Price Targets Summary
Lexicon Pharmaceuticals Inc
Lexicon Pharmaceuticals Inc
Wall Street analysts forecast LX31 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
LX31
is 5.1 EUR
with a low forecast of 1.73 EUR and a high forecast of 10.788 EUR.
Lowest
Price Target
1.73
EUR
40% Downside
Average
Price Target
5.1
EUR
76% Upside
Highest
Price Target
10.788
EUR
273% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LX31's stock price target?
Price Target
5.1
EUR
5.1
EUR
According to Wall Street analysts, the average 1-year price target for
LX31
is 5.1 EUR
with a low forecast of 1.73 EUR and a high forecast of 10.788 EUR.
What is Lexicon Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
8%
8%
For the last 14 years the
compound annual growth rate for
Lexicon Pharmaceuticals Inc's revenue is
27%.
The projected
CAGR
for the next 3 years is
8%.
